SORANIB 200MG TABLET belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney, liver, and thyroid cancer.  Kidney cancer is also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner, and forms a tumour. Cancer of the liver is known as liver cancer. When cancer occurs in the liver, it destroys healthy cells of the liver and affects the ability of the liver to function normally. Thyroid cancer occurs when cells start multiplying in the thyroid gland and form a tumour. The tumour is a collection of abnormal cells.

SORANIB 200MG TABLET contains 'Sorafenib' that falls in the category of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.

Take SORANIB 200MG TABLET as prescribed by your doctor. You are suggested to take SORANIB 200MG TABLET as long as your doctor has prescribed it after checking your medical condition.  In some cases, you may experience certain common side-effects such as itching or skin rash, acne, dry skin, vomiting, diarrhoea, and loss of appetite. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.

To treat your condition effectually, continue taking SORANIB 200MG TABLET for as long as your doctor has prescribed. Do not take SORANIB 200MG TABLET if you are pregnant or planning for pregnancy as SORANIB 200MG TABLET causes serious birth defects. SORANIB 200MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant. Elderly people are more sensitive to the medicine so the doctor may adjust the dosage according to the condition. Avoid consuming alcohol along with SORANIB 200MG TABLET as it could lead to increased dizziness.

SORANIB 200MG TABLET is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. SORANIB 200MG TABLET is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so SORANIB 200MG TABLET targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). In this way, SORANIB 200MG TABLET stops the production, spread and growth of cancerous cells in the body.

SORANIB 200MG TABLET may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Inform your doctor about your health condition and medicines to rule out any unpleasant side-effects. Before your doctor prescribes you SORANIB 200MG TABLET , tell them if you have heart problems, high blood pressure, bleeding issues, surgery, or an electrolyte imbalance (like abnormal levels of magnesium, calcium,  or potassium in the blood). SORANIB 200MG TABLET is restricted to use in persons who are sensitive to any of its constituent or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
 

• Seek medical attention immediately if you have swelling in your lower legs,  fast heartbeats, or trouble breathing. It may be a sign of a heart problem.
• SORANIB 200MG TABLET may cause bleeding so tell your doctor if you see blood in urine or stools.